$3.96
-0.05-1.25%
At close: -
$3.95
-0.01000-0.25%
After Hours: 4:00 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Larimar Therapeutics in recent months.
Browse guidance and forecast on all stocks.